Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Topic: Advancement of Imaging Diagnosis of Liver Cancer

A special issue of Hepatoma Research

ISSN 2454-2520 (Online), ISSN 2394-5079 (Print)

Submission deadline: 15 Mar 2020

Guest Editor(s)

  • Yuko Kono, MD, PhD
    Clinical Professor of Medicine and Radiology, Division of Gastroenterology & Hepatology, University of California San Diego, San Diego, USA.

    Website | E-mail

Special Issue Introduction

Hepatocellular carcinoma (HCC) is a world-wide health care problem, being the 6th most common cancer and the 4th leading cause of cancer death. It is estimated that more than 1 million patients will die from liver cancer in 2030.
A majority of HCCs are now diagnosed by imaging without tissue confirmation, so imaging plays a critical role in the diagnosis and the management of HCC.
Liver imaging reporting and data system (LI-RADS) is a standardized system for technique, interpretation, reporting and data collection for the diagnosis of HCC in high risk patients and it now includes US surveillance, CT/MR/CEUS diagnostic algorithm and CT/MRI treatment response.
In this special issue of Hepatoma Research, advancement of imaging diagnosis of HCC will be discussed by the experts in the field, from HCC surveillance with US and alternative approach with MRI, diagnosis and treatment response assessment with CT, MRI and CEUS.


Submission Deadline

15 Mar 2020

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 15 Mar 2020
Contacts: Haidi Ding, Assistant Editor,

Published Articles

© 2016-2022 OAE Publishing Inc., except certain content provided by third parties